TripleBlind has created the most complete and scalable solution for privacy enhancing computation.
TripleBlind has created the most complete and scalable solution for privacy enhancing computation.The TripleBlind solution is software-only and delivered via a simple API. It solves for a broad range of use cases, with current focus on healthcare and financial services. The company is backed by Accenture, General Catalyst and The Mayo Clinic.TripleBlind’s innovations build on well understood principles, such as federated learning and multi-party compute. Our innovations radically improve the practical use of privacy preserving technology, by adding true scalability and faster processing, with support for all data and algorithm types. TripleBlind natively supports major cloud platforms, including availability for download and purchase via cloud marketplaces. TripleBlind unlocks the intellectual property value of data, while preserving privacy and ensuring compliance with HIPAA and GDPR. TripleBlind compares favorably with other privacy preserving technologies, such as homomorphic encryption, synthetic data, and tokenization and has documented use cases for more than two dozen mission critical business problems.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 18, 2021 | Series A | $24M | 1 | General Catalyst | — | Detail |
Mar 1, 2021 | Seed | $8.20M | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 31, 2021
Evaluate.Market
|
Pre-seed | $1.60M | Analytics | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Catalyst | Yes | Series A |
Parity Responsible Technology Fund | — | Seed |